Medicine for treating phlegm retention obstructing lung type cardiac insufficiency and preparation method thereof

A technology for cardiac insufficiency and drugs, which is applied in the directions of drug combinations, pharmaceutical formulations, and medical preparations containing active ingredients, etc., can solve problems such as failure to achieve expected curative effects, high disability and mortality rates, and cardiac insufficiency, etc. To achieve the effect of improving dyspnea, no toxic side effects, and short treatment course

Inactive Publication Date: 2015-07-08
赵振荣
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

2. Give general treatment and care according to cardiac insufficiency
[0007] However, Western medicine treatment of cardiac insufficiency has a long course of treatment, high morbidity and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0073] Wherein, when the dosage form of the medicine is powder injection, its preparation method comprises the following steps:

[0074] In the first step, the raw medicinal materials are mixed in proportion, put into an ultrafine pulverizer and pulverized into a mixture composed of micron-sized particles with a volume average particle size of 0.1-10 μm and nano-sized particles with a volume-average particle size of less than 0.1 μm Powder, the powder yield of the mixed powder is at least 95%;

[0075] In the second step, add ethanol with an alcohol concentration of 85% to 95% relative to the mass of the mixed powder that is 3 to 5 times the mass of the mixed powder obtained in the first step, stir and dissolve to obtain an ethanol solution, and put the ethanol solution in Stand still for 24-36 hours under the condition of 5°C-10°C, use the percolation method to slowly percolate at a rate of 1-2ml per minute, collect the percolation liquid, concentrate and dry, and put it into...

Embodiment 1

[0088] Embodiment 1 powder injection

[0089] The preparation process of the powder injection of the present invention is as follows: take 220g of burdock, 300g of betel, 250g of houttuynia, 350g of green langgan, 220g of golden buckwheat, 340g of kudzu mushroom, 150g of gynostemma, 240g of aster, 270g of seabuckthorn, and 360g of delphinium. , Chuanbei 280g, egg leaf Liwu 320g, melon 160g, chrysanthemum seed 200g, Peucedanum 150g, wedula 30g, sea clam shell 220g, snail 300g, aster 160g, aristolochia 260g, pandanus heart 340g, low ground 120g of tea, 190g of Jinbocao, 200g of Tinglizi, 340g of Lingxiang, 190g of Yangjinhua, 200g of kohlrabi, 280g of cotyledon leaves, 330g of magnetite, 120g of zizizi, 250g of Ganoderma lucidum, 300g of thistle poppy, 230g of polygala and Torreya 300g;

[0090] In the first step, the raw medicinal materials are mixed in proportion, put into an ultrafine pulverizer and pulverized into a mixed powder composed of micron-sized particles with a vol...

Embodiment 2

[0093] Example 2 tablet

[0094] The preparation process of the tablet of the present invention is as follows: take 170g of Arctium Fructus, 270g of False Betel, 130g of Houttuynia cordata, 330g of Green Langgan, 240g of Golden Buckwheat, 350g of Pueraria chinensis, 180g of Jiaogulan, 240g of Nyster, 160g of Seabuckthorn, and 360g of delphinium , Chuanbei 300g, egg leaf Liwu 190g, melon 180g, chrysanthemum seeds 220g, Peucedanum 150g, wedula 40g, sea clam shell 130g, snail 170g, aster 200g, aristolochia 260g, pandanus heart 340g, low ground 200g of tea, 240g of Jinbocao, 140g of Tinglizi, 250g of Lingxiang, 220g of Yangjinhua, 200g of kohlrabi, 300g of cotyledon leaves, 350g of magnetite, 130g of 菥蓂子, 250g of ganoderma lucidum, 310g of thistle poppy, 180g of polygala and Torreya 250g;

[0095] The first step is to mix the raw materials of the medicine in proportion, add ethanol with an alcohol concentration of 85% that is 4 times the mass of the mixture, heat and reflux for 5...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a medicine for treating phlegm retention obstructing lung type cardiac insufficiency and a preparation method thereof. The raw medicinal materials include fructus arctii, sarmentose pepper herb, cordate houttuynia, rongkol, fagopyrum dibotrys, Japanese balanophora, gynostemma, aster fastigiatus, hippophae rhamnoides, delphinium brunnonianum royle, fritillaria cirrhosa, ligularia lessicotal, trichosanthes kirilowii maxim, fructus broussonetiae, radix peucedani, brackish-water crab, concha meretricis seu cyclinae, sea snails, aster, aristolochia championii, textile screw pine shoot, Japanese ardisia, Japanese inula herb, semen lepidii, holy basil, flos daturae, kohlrabi, thorny elaeagnus leaves, magnets, pennycress seeds, ganoderma lucidum, prickly poppies, polygala and maire yew seeds. The medicine for treating phlegm retention obstructing lung type cardiac insufficiency has the effects of purging the lung of pathogenic fire and reducing phlegm, and mainly treats phlegm retention obstructing lung type cardiac insufficiency, treatment is based on syndrome differentiation through the theory of traditional Chinese medicine, and the medicine is high in targeting performance by adjusting body circulation and pulmonary circulation qi and blood, relieves dyspnea and edema, controls arrhythmia, adjusts blood pressure, strengthens the cardiac pumping function, and has the advantages of taking effects soon, and being high in efficiency, definite in treatment effect, short in treatment course, free of toxic and side effects, low in price and the like.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical preparations, in particular to a medicine for treating cardiac insufficiency of the type of phlegm-retention obstructing the lung and a preparation method thereof. Background technique [0002] Cardiac insufficiency, also known as "heart failure", is a syndrome of heart pumping insufficiency. It means that under the condition of proper venous return, the heart cannot expel enough blood to meet the needs of systemic tissue metabolism. The human body can mobilize compensatory mechanisms in the early stage to maintain the stability of the systemic circulation, such as myocardial hyperplasia, increasing preload, reflexively exciting sympathetic nerves, and even activating the renin-angiotensin-aldosterone system and arginine vasopressin system, At this time, the heart function is in the stage of complete compensation. However, with the development of the disease, the sympathetic nerve tone ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8966A61P11/00A61P9/04A61K35/618A61K35/612A61K33/26
Inventor 朱靖孔春妍刘芳王健赵振荣
Owner 赵振荣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap